Stephen M. Stahl, MD, PhD
Editor-in-Chief
• Adjunct Professor of Psychiatry, University of California–San Diego, San Diego, California
• Honorary Visiting Senior Fellow, University of Cambridge, Cambridge, UK
• Chairman, Neuroscience Education Institute (NEI), Carlsbad, California
Dr. Stephen M. Stahl received his undergraduate and medical degrees from Northwestern University in Chicago, as a member of the honors program in Medical Education, and he received his PhD degree in pharmacology and physiology from the University of Chicago. His expertise is in clinical psychopharmacology, basic psychopharmacology, serotonin, glutamate, antipsychotics, and antidepressants.
Dr. Stahl's major interests are dedicated to producing and disseminating educational information about diseases and their treatments in psychiatry and neurology, with a special emphasis on multimedia, the Internet, and teaching how to teach.
Dr. Stahl has been cited as both one of “America's Top Psychiatrists” and one of the “Best Doctors in America.” He has written over 450 papers, and has edited eight books and written 29 others, including the best-selling and award-winning textbook, Stahl's Essential Psychopharmacology, now in its third edition; the best-selling and award-winning clinical manual, Essential Psychopharmacology Prescriber's Guide, now in its fourth edition; and the recently published series of clinical cases, Stahl's Essential Psychopharmacology Case Studies.
Gerard Sanacora, MD, PhD
Field Editor Translational Neuroscience
• Professor of Psychiatry, Yale University, and the Director of the Yale Depression Research Program, New Haven, Connecticut
Dr. Sanacora completed the Medical Scientist Training Program at the State University New York at Stony Brook, earning his PhD in physiology and biophysics, and later, his MD degree in 1994. He then moved to Yale University where he completed the Clinical Neuroscientist Training Program Residency in the Department of Psychiatry, and a Neuroimaging Scientist Training Program Fellowship.
His work concentrates largely on elucidating the pathophysiological mechanisms associated with mood and other neuropsychiatric disorders. In addition to his clinically oriented studies, he explores the effects of chronic stress on cellular biology and behavior, and examines the molecular, cellular, and behavioral effects of newly designed treatment strategies.
Dr. Sanacora was the recipient of the 2009 Anna-Monika award and the 2011 Joel Elkes Research Award for Outstanding Contributions to Psychopharmacology. His current specialties are translational neuroscience, stress, glutamate, magnetic resonance spectroscopy, and treatment-resistant mood disorders.
Carlos A. Zarate, MD
Field Editor First-in-Man and Proof-of-Concepts
• Chief Experimental Therapeutics & Pathophysiology Branch and the Section on Neurobiology and Treatment of Mood and Anxiety Disorders, Division Intramural Research Program, National Institute of Mental Health, Bethesda, Maryland
Dr. Zarate completed his residency training in psychiatry at the Massachusetts Mental Health Center/Brockton VAMC division. He later completed a fellowship in Clinical Psychopharmacology at McLean Hospital of the Consolidated Department of Psychiatry, Harvard Medical School, and remained on staff at McLean Hospital as the Director of the Bipolar and Psychotic Disorders Outpatient Services and Director of the New and Experimental Clinic. From 1998 to 2000, Dr. Zarate was the Chief of the Bipolar and Psychotic Disorders Program at the University of Massachusetts Medical School. In 2001, he joined the Mood and Anxiety Disorders Program at NIMH.
Dr. Zarate's research focuses on the pathophysiology and development of novel therapeutics for treatment-resistant mood disorders as well as the study of biosignatures of treatment response. His current specialties are major depressive disorders; mood disorders, including bipolar disorder; disorders associated with glutamate; and proof-of-concept studies.
Terence Ketter, MD
Field Editor General Clinical
• Chief, Stanford University Bipolar Disorders Clinic and Professor of Psychiatry and Behavioral Sciences, Stanford University, Palo Alto, California
Dr. Terence Ketter received his medical degree from the University of Toronto, completed internship and residency training at the University of California–San Francisco, and completed fellowship training in psychopharmacology and brain imaging and at the National Institute of Mental Health in Bethesda, Maryland, before assuming his current position at Stanford University.
His research interests include the use of brain imaging methods such as magnetic resonance imaging (MRI), magnetic resonance spectroscopy (MRS), and positron emission tomography (PET). Dr. Ketter has also studied the use of novel medications and combinations of medications in the treatment of bipolar disorders, focusing on the use of anticonvulsants, second-generation antipsychotics, and the comparative effectiveness of different pharmacotherapies.
Recently his research group's work has revealed new insights into the links between creativity, temperament, and mood disorders. His current specialties are psychiatry; mood disorders, particularly bipolar disorder; psychopharmacology; brain imaging; creativity; and psychiatric phenomenology.
Thomas L. Schwartz, MD
Deputy Editor
• Associate Professor, Department of Psychiatry at SUNY Upstate Medical University, Syracuse, New York
• Director of Adult Clinical Services and Undergraduate Medical Student Education for the Department of Psychiatry at SUNY Upstate Medical University, Syracuse, New York
Dr. Thomas Schwartz provides direct resident supervision and lectures in several courses at SUNY Upstate Medical University. He directs and organizes CME events for the Psychiatry Department. Dr. Schwartz maintains a small private practice and consults for the Indian Health Service.
Dr. Schwartz has psychopharmacology clinical trial research experience in treatment-resistant depression, anxiety disorders, and psychosomatic illness. He serves as an active member of several academic and administrative committees with an emphasis on curriculum development. He has published manuscripts and books regarding his work in several major clinical areas, and is active in speaking in support of his research.
